CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Consensus2019 Oct 15;74(15):1966-2011.

JOURNAL:J Am Coll Cardiol. Article Link

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee

Hollenberg SM, Warner Stevenson L, Ahmad T Keywords: ACC Expert Consensus Decision Pathway; CHF; angiotensin receptor-neprilysin inhibitors; beta blockers; comorbidities; diuretics; guideline-directed medical therapy; heart failure

FULL TEXT PDF